PDC-E3BP is not a dominant T-cell autoantigen in primary biliary cirrhosis

Liver International

Volumn 26, Issue 4, 2006, Pages 406-413

  McHugh, Anna ^a   Robe, Amanda J ^a   Palmer, Jeremy M ^a   Jones, David E J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Autoimmune disease; Human study; Immune tolerance; Liver cirrhosis biliary; Pyruvate dehydrogenase complex; RegulatoryT cell

Indexed keywords

AUTOANTIGEN; PYRUVATE DEHYDROGENASE COMPLEX; T LYMPHOCYTE ANTIGEN;

ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNE DISEASE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; PRIMARY BILIARY CIRRHOSIS; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

AUTOANTIGENS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CROSS REACTIONS; DIHYDROLIPOYLLYSINE-RESIDUE ACETYLTRANSFERASE; HUMANS; IMMUNE TOLERANCE; LIVER CIRRHOSIS, BILIARY; MITOCHONDRIAL PROTEINS; PYRUVATE DEHYDROGENASE COMPLEX; RECEPTORS, INTERLEUKIN-2;

EID: 33645742859     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2006.01253.x     Document Type: Article

References (36)

1. Yeaman S J, Kirby J A, Jones D E J. Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis. Immunol Rev 2000; 174: 238-49.
2. Jones D E J. Pathogenesis of primary biliary cirrhosis. J Hepatol 2003; 39: 639-48.
3. Yeaman S J, Fussey S P, Danner D J, et al. Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet 1988; i: 1067-70.
4. van de Water J, Fregeau D, Davis P, et al. Autoantibodies of primary biliary cirrhosis recognise dihydrolipoamide acetyltransferase and inhibit enzyme function. J Immunol 1988; 141: 2321-4.
5. Heseltine L, Turner I B, Fussey S P M, et al. Primary biliary cirrhosis: quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression. Gastroenterology 1990; 99: 1786-92.
6. Jones D E J. Primary biliary cirrhosis. Autoimmunity 2004; 37: 325-8.
7. Dubel L, Tanaka A, Leung S, et al. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide protein (E3BP) and the cleavage proteins in primary biliary cirrhosis. Hepatology 1999; 9: 1013-8
8. Palmer J M, Jones D E J, Quinn J, et al. Characterisation of the autoantibody responses to recombinant E3 binding protein (protein X) of pyruvate dehydrogenase in primary biliary cirrhosis. Hepatology 1999; 30: 21-6.
9. Quinn J, Diamond A G, Palmer J M, et al. Lipoylated and unlipoylated domains of human PDC-E2 as autoantigens in primary biliary cirrhosis: significance of lipoate attachment. Hepatology 1993; 18: 1384-91.
10. Gershwin M E, Mackay I R, Sturgess Acoppel R L. Identification and specificity of a cDNA encoding 70 kD mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987; 138: 3525-31.
11. Harris R A, Bowker-Kinley M M, Wu P, et al. Dihydrolipoamide dehydrogenase-binding protein of the human pyruvate dehydrogenase complex. J Biol Chem 1997; 272: 19746-51.
12. Coppel R L, Mcneilage L J, Surh C D, et al. Primary structure of the human M2 mitochondrial autoantigen in primary biliary cirrhosis. Proc Natl Acad Sci USA 1988; 85: 7317-21.
13. Surh C D, Coppel Rgerswin M E. Structural requirement for autoreacitiviy on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis. J Immunol 1990; 144: 3367-74.
14. Howard M J, Fuller C, Broadhurst R W, et al. Three dimensional structure of the major autoantigen in primary biliary cirrhosis. Gastroenterology 1998; 115: 139-46.
15. van de Water J, Ansari A A, Surh C D, et al. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T-cell response of primary biliary cirrhosis. J Immunol 1991; 146: 89-94.
16. Shimoda S, Nakamura M, Ishibashi H, et al. HLA DRB4 0101-restricted immunodominant T-cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: Evidence of molecular mimicry in human autoimmune disease. J Exp Med 1995; 181: 1835-45.
17. Shimoda S, Nakamura M, Shigematsu H, et al. Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis. Hepatology 2000; 31: 1212-6.
18. Shimoda S, van de Water J, Ansari A, et al. Identification and precursor frequency analysis of a common T-cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest 1998; 102: 1831-40.
19. Long S A, Quan C, van de Water J, et al. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: Connecting xenobiotics with primary biliary cirrhosis. J Immunol 2001; 167: 2956-63.
20. Leung P S, Quan C, Park O, et al. Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces anti-mitochondrial antibodies. J Immunol 2003; 170: 5326-32.
21. Palmer J M, Robe A J, Burt A D, et al. Covalent modification as a mechanism for the breakdown of immune tolerance to pyruvate dehydrogenase complex in the mouse. Hepatology 2004; 39: 1583-92.
22. Jones D E J, Palmer J M, Robe A, Jkirby J A. Oral tolerisation to pyruvate dehydrogenase complex as a potential therapy for primary biliary cirrhosis. Autoimmunity 2002; 35: 537 - 44.
23. Metcalf J V, Bhopal R S, Gray James O F W. Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle-upon-Tyne, England. Int J Epidemiol 1997; 26: 830-6.
24. Jones D E J, Palmer J M, Yeaman S J, et al. T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis. Hepatology 1995; 21: 995-1002.
25. Wing K, Ekmark A, Karlsson H, et al. Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood. Immunology 2002; 106: 190-9.
26. Suri-Payer E, Amar A Z, Thornton A, Mshevach E M. CD4+ CD25+ T cells inhibit both the induction and effector function of autoreactive T-cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998; 160: 1212-8.
27. Shevach E M. Regulatory T-cells in autoimmunity. Annu Rev Immunol 2000; 18: 423-49.
28. Lepault Fgagnerault M C. Characterization of lperipheral regulatroy CD4+ T cells that prevent diabetes onset in nonobese diabetic mice. J Immunol 2000; 164: 240-7.
29. Mchugh R, Sshevach E M. Depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient for induction of organ-specific autoimmune disease. J Immunol 2002; 168: 5979-83.
30. Alyanakian M-A, You S, Damotte D, et al. Diversity of regulatory CD4+ T cells controlling distinct organ-specific autoimmune diseases. Proc Natl Acad Sci USA 2003; 100: 15806-11.
31. Tanabe Y Su Ldavid M. Impaired development of CD4+ CD25+ regulatory T-cells in the absence of STAT1: Increased susceptibility to autoimmune disease. J Exp Med 2004 199: 25-34
32. Jones D E J, Palmer J M, Yeaman S J, et al. T-cell responses to native human proteins in primary biliary cirrhosis. Clin Exp Immunol 1997; 116: 562-8
33. Robe A J, Kirby J, Jones D E, Jpalmer J M. A Key role for autoreactive B-cells in the breakdown of T-cell tolerance to pyruvate dehydrogenase complex. Hepatology 2005, in press.
34. Shigematsu H, Shimoda S, Nakamura M, et al. Fine specificity of T cells reactive to human PDC-E2 163-176 peptide, the immunodominant autoantigen in primary biliary cirrhosis: Implications for molecular mimicry and cross-recognition among mitochondrial autoantigens. Hepatology 2000; 32: 901-9.
35. Watt F E, James O F, Wjones D E J. Patterns of autoimmunity in PBC patients and their families. Quarterly Journal of Medicine 2004; 97: 397-406.
36. Palmer J M, Bassendine M F, James O F, Wyeaman S J. Human pyruvate dehydrogenase complex as an autoantigen in primary biliary cirrhosis. Clin Sci 1993; 85: 289-93.